Skin autofluorescence, a non-invasive biomarker for advanced glycation end products, is associated with the metabolic syndrome and its individual components

BACKGROUND: The metabolic syndrome (MetS) comprises several cardiometabolic risk factors associated with increased risk for both type 2 diabetes and cardiovascular disease. Skin autofluorescence (SAF), a non-invasive biomarker of advanced glycation end products accumulation, is associated with cardi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Diabetol Metab Syndr
Main Authors: van Waateringe, Robert P., Slagter, Sandra N., van Beek, Andre P., van der Klauw, Melanie M., van Vliet-Ostaptchouk, Jana V., Graaff, Reindert, Paterson, Andrew D., Lutgers, Helen L., Wolffenbuttel, Bruce H. R.
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2017
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5450154/
https://ncbi.nlm.nih.gov/pubmed/28572855
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13098-017-0241-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados